BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33066067)

  • 1. Identification of Prognosis Associated microRNAs in HNSCC Subtypes Based on TCGA Dataset.
    Chamorro Petronacci CM; García García A; Padín Iruegas E; Rivas Mundiña B; Lorenzo Pouso AI; Pérez Sayáns M
    Medicina (Kaunas); 2020 Oct; 56(10):. PubMed ID: 33066067
    [No Abstract]   [Full Text] [Related]  

  • 2. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two miRNA prognostic signatures of head and neck squamous cell carcinoma: A bioinformatic analysis based on the TCGA dataset.
    Wu C; Tong L; Wu C; Chen D; Chen J; Li Q; Jia F; Huang Z
    Cancer Med; 2020 Apr; 9(8):2631-2642. PubMed ID: 32064753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks.
    Yang L; Lu P; Yang X; Li K; Chen X; Qu S
    Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis.
    Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T
    Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic microRNA signatures derived from The Cancer Genome Atlas for head and neck squamous cell carcinomas.
    Wong N; Khwaja SS; Baker CM; Gay HA; Thorstad WL; Daly MD; Lewis JS; Wang X
    Cancer Med; 2016 Jul; 5(7):1619-28. PubMed ID: 27109697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
    Zhao X; Cui L
    J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer.
    Saleh AD; Cheng H; Martin SE; Si H; Ormanoglu P; Carlson S; Clavijo PE; Yang X; Das R; Cornelius S; Couper J; Chepeha D; Danilova L; Harris TM; Prystowsky MB; Childs GJ; Smith RV; Robertson AG; Jones SJM; Cherniack AD; Kim SS; Rait A; Pirollo KF; Chang EH; Chen Z; Van Waes C
    Clin Cancer Res; 2019 May; 25(9):2860-2873. PubMed ID: 30723145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-96-5p targets PTEN expression affecting radio-chemosensitivity of HNSCC cells.
    Vahabi M; Pulito C; Sacconi A; Donzelli S; D'Andrea M; Manciocco V; Pellini R; Paci P; Sanguineti G; Strigari L; Spriano G; Muti P; Pandolfi PP; Strano S; Safarian S; Ganci F; Blandino G
    J Exp Clin Cancer Res; 2019 Mar; 38(1):141. PubMed ID: 30925916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC.
    Liu C; Yu Z; Huang S; Zhao Q; Sun Z; Fletcher C; Jiang Y; Zhang D
    EBioMedicine; 2019 Dec; 50():135-143. PubMed ID: 31780396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating microRNAs modulating glycolysis as non-invasive prognostic biomarkers of HNSCC.
    Avilés-Jurado FX; Muñoz C; Meler C; Flores JC; Gumà J; Benaiges E; Mora J; Camacho M; León X; Vilaseca I; Terra X
    Eur Arch Otorhinolaryngol; 2021 May; 278(5):1585-1594. PubMed ID: 32737645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.
    Koshizuka K; Hanazawa T; Kikkawa N; Katada K; Okato A; Arai T; Idichi T; Osako Y; Okamoto Y; Seki N
    Auris Nasus Larynx; 2018 Aug; 45(4):854-865. PubMed ID: 29233721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High eukaryotic initiation factor 5A2 expression predicts poor prognosis and may participate in the SNHG16/miR-10b-5p/EIF5A2 regulatory axis in head and neck squamous cell carcinoma.
    Ye S; Wang D; Jin M; Du J; Chen X; Zhang H; Zhou C; Fang S; Liu K
    J Clin Lab Anal; 2023 Jan; 37(1):e24820. PubMed ID: 36550070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation.
    Severino P; Brüggemann H; Andreghetto FM; Camps C; Klingbeil Mde F; de Pereira WO; Soares RM; Moyses R; Wünsch-Filho V; Mathor MB; Nunes FD; Ragoussis J; Tajara EH
    BMC Cancer; 2013 Nov; 13():533. PubMed ID: 24209638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets.
    Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W
    Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
    Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
    Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Possible Molecular Mechanisms of microRNA-205-5p in Patients With Head and Neck Squamous Cell Carcinoma.
    Zhou Z; Liu C; Liu K; Lv M; Li B; Lan Z; Chen W; Kang M
    Technol Cancer Res Treat; 2020; 19():1533033820980110. PubMed ID: 33327871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
    Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
    Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.